Effect of Curcumin on Oxidative Stress, Inflammatory Response and
Kidney Biochemical Parameters Among Kidney Disease Patients: A
Systematic Review

Elham      Emami; Parham      Talebi-Boroujeni; Catherine   M.T.   Sherwin; Saeid      Heidari-Soureshjani; Somayeh      Mohammadi
doi:10.2174/2210315512666220617113802
Abstract

Background: Chronic kidney disease (CKD) and end-stage renal diseases have high global morbidity and mortality.
Objective: We aimed to investigate the antioxidant and anti-inflammatory properties of curcumin and its impact on kidney biochemical parameters associated with kidney disease among CKD and hemodialysis (HD) patients.
Methods: The intended keywords were used in the literature search. Clinical trial studies from the beginning to December 25th, 2021, indexed in the Institute for Scientific Information (ISI), Scopus, and PubMed databases, were included in the review. Records with no accessible full texts, non-English language articles, and studies that were not related to the study aim were excluded. The agreement for exclusion required all authors to concur. Finally, after reviewing all available literature, 27 articles were included in this systematic review.
Results: Curcumin supplementation increased antioxidant capacity by improving catalase (CAT) activity, free radical scavenging activity, and nuclear factor erythroid 2-related factor 2 (Nrf2). It also reduced hs-CRP, IL-6, and TNF-a levels in patients with CKD and HD patients. Different results were reported regarding the effect of curcumin on kidney-related biochemical parameters. But mostly, the results showed that no significant changes were seen in glomerular filtration (GFR), albumin (Alb), serum creatinine (sCr), proteinuria (PRO), and blood urea nitrogen (BUN) in these patients.
Conclusion: Although it seems curcumin improved antioxidant capacity and decreased inflammatory cytokines in CKD and HD patients, it did not affect renal biochemical parameters. More clinical studies with larger sample sizes appear to be needed.
Keywords: Curcumin, oxidative stress, inflammation, chronic kidney disease, hemodialysis, clinical trial
[1]
Hill, N.R.; Fatoba, S.T.; Oke, J.L.; Hirst, J.A.; O’Callaghan, C.A.; Lasserson, D.S.; Hobbs, F.D.R. Global prevalence of chronic kidney disease - a systematic review and meta-analysis. PLoS One,  2016, 11(7), e0158765-e0158765.
 [http://dx.doi.org/10.1371/journal.pone.0158765] [PMID:  27383068]

[2]
Ammirati, A.L. Chronic kidney disease. Rev. Assoc. Med. Bras. (1992),,  2020, 66(Suppl 1), 03-09.

[3]
Pan, S.Y.; Litscher, G. Traditional medicines in the world: Where to go next? Evid. Based Complement. Altern. Med.,,  2014, 2014
 [http://dx.doi.org/10.1155/2014/739895]

[4]
Duan, J.; Wang, C.; Liu, D.; Qiao, Y.; Pan, S.; Jiang, D.; Zhao, Z.; Liang, L.; Tian, F.; Yu, P.; Zhang, Y.; Zhao, H.; Liu, Z. Prevalence and risk factors of chronic kidney disease and diabetic kidney disease in Chinese rural residents: A cross-sectional survey. Sci. Rep.,  2019, 9(1), 10408-10408.
 [http://dx.doi.org/10.1038/s41598-019-46857-7] [PMID:  31320683]

[5]
Pergola, P.E.; Pecoits-Filho, R.; Winkelmayer, W.C.; Spinowitz, B.; Rochette, S.; Thompson-Leduc, P.; Lefebvre, P.; Shafai, G.; Bozas, A.; Sanon, M.; Krasa, H.B. Economic burden and health-related quality of life associated with current treatments for anaemia in patients with ckd not on dialysis: A systematic review. PharmacoEconom. Open,  2019, 3(4), 463-478.
 [http://dx.doi.org/10.1007/s41669-019-0132-5] [PMID:  30968369]

[6]
Carrero, J.J.; Yilmaz, M.I.; Lindholm, B.; Stenvinkel, P. Cytokine dysregulation in chronic kidney disease: How can we treat it? Blood Purif.,  2008, 26(3), 291-299.
 [http://dx.doi.org/10.1159/000126926] [PMID:  18421214]

[7]
Tinti, F.; Lai, S.; Noce, A.; Rotondi, S.; Marrone, G.; Mazzaferro, S.; Di Daniele, N.; Mitterhofer, A.P. Chronic kidney disease as a systemic inflammatory syndrome: Update on mechanisms involved and potential treatment. Life (Basel),  2021, 11(5), 419.
 [http://dx.doi.org/10.3390/life11050419] [PMID:  34063052]

[8]
de Almeida Alvarenga, L.; de Oliveira Leal, V.; Borges, N.A.; de Aguiar, A.S.; Faxén-Irving, G.; Stenvinkel, P.; Lindholm, B.; Mafra, D. Curcumin-A promising nutritional strategy for chronic kidney disease patients. J. Funct. Foods,  2018, 40, 715-721.
 [http://dx.doi.org/10.1016/j.jff.2017.12.015]

[9]
Slee, A.D. Exploring metabolic dysfunction in chronic kidney disease. Nutr. Metab. (Lond.),  2012, 9(1), 36-36.
 [http://dx.doi.org/10.1186/1743-7075-9-36] [PMID:  22537670]

[10]
Collaboration, G.B.D.C.K.D. Global, regional, and national burden of chronic kidney disease, 1990-2017: A systematic analysis for the global burden of disease study 2017. Lancet,  2020, 395(10225), 709-733.
 [http://dx.doi.org/10.1016/S0140-6736(20)30045-3] [PMID:  32061315]

[11]
Hasan, M.; Sutradhar, I.; Gupta, R.D.; Sarker, M. Prevalence of chronic kidney disease in South Asia: A systematic review. BMC Nephrol.,  2018, 19(1), 291-291.
 [http://dx.doi.org/10.1186/s12882-018-1072-5] [PMID:  30352554]

[12]
Chen, T.K.; Knicely, D.H.; Grams, M.E. Chronic kidney disease diagnosis and management: A review. JAMA,  2019, 322(13), 1294-1304.
 [http://dx.doi.org/10.1001/jama.2019.14745] [PMID:  31573641]

[13]
Subeesh, V.K.; Abraham, R.; Satya Sai, M.V.; Koonisetty, K.S. Evaluation of prescribing practices and drug-related problems in chronic kidney disease patients: A cross-sectional study. Perspect. Clin. Res.,  2020, 11(2), 70-74.
 [http://dx.doi.org/10.4103/picr.PICR_110_18] [PMID:  32670831]

[14]
Whittaker, C.F.; Miklich, M.A.; Patel, R.S.; Fink, J.C. Medication safety principles and practice in CKD. Clin. J. Am. Soc. Nephrol.,  2018, 13(11), 1738-1746.
 [http://dx.doi.org/10.2215/CJN.00580118] [PMID:  29915131]

[15]
Welz, A.N.; Emberger-Klein, A.; Menrad, K. Why people use herbal medicine: Insights from a focus-group study in Germany. BMC Complement. Altern. Med.,  2018, 18(1), 92.
 [http://dx.doi.org/10.1186/s12906-018-2160-6] [PMID:  29544493]

[16]
Yuan, H.; Ma, Q.; Ye, L.; Piao, G. The traditional medicine and modern medicine from natural products. Molecules,  2016, 21(5), 559.
 [http://dx.doi.org/10.3390/molecules21050559] [PMID:  27136524]

[17]
Fjær, E.L.; Landet, E.R.; McNamara, C.L.; Eikemo, T.A. The use of complementary and alternative medicine (CAM) in Europe. BMC Complement Med Ther,  2020, 20(1), 108.
 [http://dx.doi.org/10.1186/s12906-020-02903-w] [PMID:  32252735]

[18]
Bagherniya, M.; Soleimani, D.; Rouhani, M.H.; Askari, G.; Sathyapalan, T.; Sahebkar, A. The use of curcumin for the treatment of renal disorders: A systematic review of randomized controlled trials. Adv. Exp. Med. Biol.,  2021, 1291, 327-343.
 [http://dx.doi.org/10.1007/978-3-030-56153-6_19] [PMID:  34331699]

[19]
Alvarenga, L.; Salarolli, R.; Cardozo, L.F.M.F.; Santos, R.S.; de Brito, J.S.; Kemp, J.A.; Reis, D.; de Paiva, B.R.; Stenvinkel, P.; Lindholm, B.; Fouque, D.; Mafra, D. Impact of curcumin supplementation on expression of inflammatory transcription factors in hemodialysis patients: A pilot randomized, double-blind, controlled study. Clin. Nutr.,  2020, 39(12), 3594-3600.
 [http://dx.doi.org/10.1016/j.clnu.2020.03.007] [PMID:  32204978]

[20]
Hewlings, S.J.; Kalman, D.S. Curcumin: A review of its effects on human health. Foods,  2017, 6(10), E92.
 [http://dx.doi.org/10.3390/foods6100092] [PMID:  29065496]

[21]
Jiménez-Osorio, A.S. García-Niño, W.R.; González-Reyes, S.; Álvarez-Mejía, A.E.;Guerra-León, S.; Salazar-Segovia, J.; Falcón, I.; Montes de Oca-Solano, H.; Madero, M.; Pedraza-Chaverri, J. The effect of dietary supplementation with curcumin on redox status and nrf2 activation in patients with nondiabetic or diabetic proteinuric chronic kidney disease: A pilot study. J. Ren. Nutr.,  2016, 26(4), 237-244.
 [http://dx.doi.org/10.1053/j.jrn.2016.01.013] [PMID:  26915483]

[22]
Rodrigues, H.C.N.; Martins, T.F.P.; Santana, N.C.F.E.S.; Braga, C.C.; Silva, M.A.C.; Cunha, L.C.D.; Sugizaki, C.S.A.; Freitas, A.T.V.S.; Costa, N.A.; Peixoto, M.D.R.G. Antioxidant and anti-inflammatory response to curcumin supplementation in hemodialysis patients: A randomized, double-blind, placebo-controlled clinical trial. Clin. Nutr. ESPEN,  2021, 44, 136-142.
 [http://dx.doi.org/10.1016/j.clnesp.2021.06.006] [PMID:  34330457]

[23]
Weir, M.A.; Walsh, M.; Cuerden, M.S.; Sontrop, J.M.; Chambers, L.C.; Garg, A.X. Micro-particle curcumin for the treatment of chronic kidney disease-1: Study protocol for a multicenter clinical trial. Can. J. Kidney Health Dis.,  2018, 5, 2054358118813088.
 [http://dx.doi.org/10.1177/2054358118813088] [PMID:  30619615]

[24]
Nowak, K.L.; Farmer-Bailey, H.; Cadnapaphornchai, M.A.; You, Z.; George, D.; Wang, W.; Jovanovich, A.; Soranno, D.E.; Gitomer, B.; Chonchol, M. Curcumin therapy to treat vascular dysfunction in children and young adults with autosomal dominant polycystic kidney disease: Design and baseline characteristics of participants. Contemp. Clin. Trials Commun.,  2020, 19, 100635.
 [http://dx.doi.org/10.1016/j.conctc.2020.100635] [PMID:  33294724]

[25]
Salarolli, R.T.; Alvarenga, L.; Cardozo, L.; Teixeira, K.T.R. de, S.G.M.L.; Lima, J.D; Rodrigues, S.D.; Nakao, L.S.; Fouque, D; Mafra, D. Can curcumin supplementation reduce plasma levels of gutderived uremic toxins in hemodialysis patients? A pilot randomized, double-blind, controlled study 2021, 53(6), 1231-1238.

[26]
Moreillon, J.J.; Bowden, R.G.; Deike, E.; Griggs, J.; Wilson, R.; Shelmadine, B.; Cooke, M.; Beaujean, A. The use of an anti-inflammatory supplement in patients with chronic kidney disease. J. Complement. Integr. Med.,  2013, 10(1), 10.
 [http://dx.doi.org/10.1515/jcim-2012-0011] [PMID:  23828329]

[27]
Pakfetrat, M.; Akmali, M.; Malekmakan, L.; Dabaghimanesh, M.; Khorsand, M. Role of turmeric in oxidative modulation in end-stage renal disease patients. Hemodial. Int.,  2015, 19(1), 124-131.
 [http://dx.doi.org/10.1111/hdi.12204] [PMID:  25131305]

[28]
Yang, H.; Xu, W.; Zhou, Z.; Liu, J.; Li, X.; Chen, L.; Weng, J.; Yu, Z. Curcumin attenuates urinary excretion of albumin in type II diabetic patients with enhancing nuclear factor erythroid-derived 2-like 2 (Nrf2) system and repressing inflammatory signaling efficacies. Exp. Clin. Endocrinol. Diabetes,  2015, 123(6), 360-367.
 [http://dx.doi.org/10.1055/s-0035-1545345] [PMID:  25875220]

[29]
Khajehdehi, P.; Pakfetrat, M.; Javidnia, K.; Azad, F.; Malekmakan, L.; Nasab, M.H.; Dehghanzadeh, G. Oral supplementation of turmeric attenuates proteinuria, transforming growth factor-β and interleukin-8 levels in patients with overt type 2 diabetic nephropathy: A randomized, double-blind and placebo-controlled study. Scand. J. Urol. Nephrol.,  2011, 45(5), 365-370.
 [http://dx.doi.org/10.3109/00365599.2011.585622] [PMID:  21627399]

[30]
Pakfetrat, M.; Basiri, F.; Malekmakan, L.; Roozbeh, J. Effects of turmeric on uremic pruritus in end stage renal disease patients: A double-blind randomized clinical trial. J. Nephrol.,  2014, 27(2), 203-207.
 [http://dx.doi.org/10.1007/s40620-014-0039-2] [PMID:  24482090]

[31]
Samadian, F.; Dalili, N.; Poor-Reza Gholi, F.; Fattah, M.; Malih, N.; Nafar, M.; Firoozan, A.; Ahmadpoor, P.; Samavat, S.; Ziaie, S. Evaluation of Curcumin’s effect on inflammation in hemodialysis patients. Clin. Nutr. ESPEN,  2017, 22, 19-23.
 [http://dx.doi.org/10.1016/j.clnesp.2017.09.006] [PMID:  29415829]

[32]
Kabodan, M.H.; Kooshki, A.; Rad, M.; Tabarraie, Y.; Sharifipour, F. Investigating the effect of curcumin supplement consumption on systematic inflammation in hemodialysis patients. Int. J. Life Sci. Pharma Res.,  2018, 8(4), 39-47.
 [http://dx.doi.org/10.22376/ijpbs/lpr.2018.8.4.L39-47]

[33]
Shafabakhsh, R.; Asemi, Z.; Reiner, Z.; Soleimani, A.; Aghadavod, E.; Bahmani, F. The effects of nano-curcumin on metabolic status in patients with diabetes on hemodialysis, a randomized, double blind, placebo-controlled trial. Iran. J. Kidney Dis.,  2020, 14(4), 290-299.
 [PMID:  32655024]

[34]
Vafadar Afshar, G.; Rasmi, Y.; Yaghmaei, P.; Khadem-Ansari, M.H.; Makhdomii, K.; Rasooli, J. The effects of nano-curcumin supplementation on serum level of hs-crp, adhesion molecules, and lipid profiles in hemodialysis patients, a randomized controlled clinical trial. Iran. J. Kidney Dis.,  2020, 14(1), 52-61.
 [PMID:  32156842]

[35]
Vafadar-Afshar, G.; Rasmi, Y.; Yaghmaei, P.; Khadem-Ansari, M.H.; Makhdoomi, K.; Rasouli, J. The effects of nanocurcumin supplementation on inflammation in hemodialysis patients: A randomized controlled trial. Hemodial. Int.,  2021, 25(2), 232-239.
 [http://dx.doi.org/10.1111/hdi.12911] [PMID:  33559343]

[36]
Shoskes, D.; Lapierre, C.; Cruz-Correa, M.; Muruve, N.; Rosario, R.; Fromkin, B.; Braun, M.; Copley, J. Beneficial effects of the bioflavonoids curcumin and quercetin on early function in cadaveric renal transplantation: A randomized placebo controlled trial. Transplantation,  2005, 80(11), 1556-1559.
 [http://dx.doi.org/10.1097/01.tp.0000183290.64309.21] [PMID:  16371925]

[37]
Hami, M.; Bigdeli, A.; Khameneh Bagheri, R.; Rajabi, O.; Salehi, M.; Zahedi Avval, F. The effect of curcumin in prevention of contrast nephropathy following coronary angiography or angioplasty in CKD patients. Iran. J. Kidney Dis.,  2019, 13(5), 304-309.
 [PMID:  31705746]

[38]
Murillo Ortiz, B.O.; Fuentes Preciado, A.R. Ramírez Emiliano, J.; Martínez Garza, S.; Ramos Rodríguez, E.; de Alba Macías, L.A. Recovery of bone and muscle mass in patients with chronic kidney disease and iron overload on hemodialysis and taking combined supplementation with curcumin and resveratrol. Clin. Interv. Aging,  2019, 14, 2055-2062.
 [http://dx.doi.org/10.2147/CIA.S223805] [PMID:  31819387]

[39]
Vanaie, A.; Shahidi, S.; Iraj, B.; Siadat, Z.D.; Kabirzade, M.; Shakiba, F.; Mohammadi, M.; Parvizian, H. Curcumin as a major active component of turmeric attenuates proteinuria in patients with overt diabetic nephropathy. J. Res. Med. Sci.,  2019, 24(1), 77.
 [http://dx.doi.org/10.4103/jrms.JRMS_1055_18] [PMID:  31523263]

[40]
Ravindran, P.; Nirmal Babu, K.; Sivaraman, K. Turmeric: The golden spice of life. Turmeric. The Genus Curcuma; CRC Press: Boca Raton, FL, USA, 2007, pp. 1-14.

[41]
Luis, P.B.; Gordon, O.N.; Nakashima, F.; Joseph, A.I.; Shibata, T.; Uchida, K.; Schneider, C. Oxidative metabolism of curcumin-glucuronide by peroxidases and isolated human leukocytes. Biochem. Pharmacol.,  2017, 132, 143-149.
 [http://dx.doi.org/10.1016/j.bcp.2017.03.002] [PMID:  28274615]

[42]
Anand, P.; Thomas, S.G.; Kunnumakkara, A.B.; Sundaram, C.; Harikumar, K.B.; Sung, B.; Tharakan, S.T.; Misra, K.; Priyadarsini, I.K.; Rajasekharan, K.N.; Aggarwal, B.B. Biological activities of curcumin and its analogues (Congeners) made by man and mother nature. Biochem. Pharmacol.,  2008, 76(11), 1590-1611.
 [http://dx.doi.org/10.1016/j.bcp.2008.08.008] [PMID:  18775680]

[43]
Sahebkar, A.; Serban, M-C.; Ursoniu, S.; Banach, M. Effect of curcuminoids on oxidative stress: A systematic review and meta-analysis of randomized controlled trials. J. Funct. Foods,  2015, 18, 898-909.
 [http://dx.doi.org/10.1016/j.jff.2015.01.005]

[44]
Trujillo, J.; Chirino, Y.I. Molina-Jijón, E.; Andérica-Romero, A.C.; Tapia, E.; Pedraza-Chaverrí, J. Renoprotective effect of the antioxidant curcumin: Recent findings. Redox Biol.,  2013, 1(1), 448-456.
 [http://dx.doi.org/10.1016/j.redox.2013.09.003] [PMID:  24191240]

[45]
Cui, X.; Song, H.; Su, J. Curcumin attenuates hypoxic-ischemic brain injury in neonatal rats through induction of nuclear factor erythroid-2-related factor 2 and heme oxygenase-1. Exp. Ther. Med.,  2017, 14(2), 1512-1518.
 [http://dx.doi.org/10.3892/etm.2017.4683] [PMID:  28781627]

[46]
Cardozo, L.F.; Pedruzzi, L.M.; Stenvinkel, P.; Stockler-Pinto, M.B.; Daleprane, J.B.; Leite, M., Jr; Mafra, D. Nutritional strategies to modulate inflammation and oxidative stress pathways via activation of the master antioxidant switch Nrf2. Biochimie,  2013, 95(8), 1525-1533.
 [http://dx.doi.org/10.1016/j.biochi.2013.04.012] [PMID:  23643732]

[47]
Zhao, R.; Yang, B.; Wang, L.; Xue, P.; Deng, B.; Zhang, G.; Jiang, S.; Zhang, M.; Liu, M.; Pi, J. Curcumin protects human keratinocytes against inorganic arsenite-induced acute cytotoxicity through an NRF2-dependent mechanism. Oxid. Med. Cell. Longev.,,  2013, 2013
 [http://dx.doi.org/10.1155/2013/412576]

[48]
Liu, Z.J.; Liu, H.Q.; Xiao, C.; Fan, H.Z.; Huang, Q.; Liu, Y.H.; Wang, Y. Curcumin protects neurons against oxygen-glucose deprivation/reoxygenation-induced injury through activation of peroxisome proliferator-activated receptor-γ function. J. Neurosci. Res.,  2014, 92(11), 1549-1559.
 [http://dx.doi.org/10.1002/jnr.23438] [PMID:  24975470]

[49]
Rahimi, H.R.; Mohammadpour, A.H.; Dastani, M.; Jaafari, M.R.; Abnous, K.; Ghayour Mobarhan, M.; Kazemi Oskuee, R. The effect of nano-curcumin on HbA1c, fasting blood glucose, and lipid profile in diabetic subjects: A randomized clinical trial. Avicenna J. Phytomed.,  2016, 6(5), 567-577.
 [PMID:  27761427]

[50]
Zandi, E.; Rothwarf, D.M.; Delhase, M.; Hayakawa, M.; Karin, M. The IkB kinase complex (IKK) contains two kinase subunits, IKKa and IKKb, necessary for IkB phosphorylation and NF-kB activation. Cell,  1997, 91(2), 243-252.
 [http://dx.doi.org/10.1016/S0092-8674(00)80406-7] [PMID:  9346241]

[51]
Li, L.; Aggarwal, B.B.; Shishodia, S.; Abbruzzese, J.; Kurzrock, R. Nuclear factor-kappaB and IkappaB kinase are constitutively active in human pancreatic cells, and their down-regulation by curcumin (diferuloylmethane) is associated with the suppression of proliferation and the induction of apoptosis. Cancer,  2004, 101(10), 2351-2362.
 [http://dx.doi.org/10.1002/cncr.20605] [PMID:  15476283]

[52]
Shehzad, A.; Qureshi, M.; Anwar, M.N.; Lee, Y.S. Multifunctional curcumin mediate multitherapeutic effects. J. Food Sci.,  2017, 82(9), 2006-2015.
 [http://dx.doi.org/10.1111/1750-3841.13793] [PMID:  28771714]

[53]
Liu, Z.; Bao, X.; Jia, S.; Hu, Y.Z Y. Z., constructing the screening cell model of PPARγ and to validate whether the curcumin is the natural agonist of PPARγ. J. Apoplexy Nervous Dis.,  2011, 28, 872-874.

[54]
Liu, Z.-J.; Liu, W.; Liu, L.; Xiao, C.; Wang, Y.; Jiao, J.-S. Curcumin protects neuron against cerebral ischemia-induced inflammation through improving PPAR-gamma function Evid. Based Complement. Altern. Med.,,  2013, 2013
 [http://dx.doi.org/10.1155/2013/470975]

[55]
Semlali, A.; Contant, C.; Al-Otaibi, B.; Al-Jammaz, I.; Chandad, F. The curcumin analog (PAC) suppressed cell survival and induced apoptosis and autophagy in oral cancer cells. Sci. Rep.,  2021, 11(1), 11701-11701.
 [http://dx.doi.org/10.1038/s41598-021-90754-x] [PMID:  34083581]

[56]
Shah, B.H.; Nawaz, Z.; Pertani, S.A.; Roomi, A.; Mahmood, H.; Saeed, S.A.; Gilani, A.H. Inhibitory effect of curcumin, a food spice from turmeric, on platelet-activating factor- and arachidonic acid-mediated platelet aggregation through inhibition of thromboxane formation and Ca2+ signaling. Biochem. Pharmacol.,  1999, 58(7), 1167-1172.
 [http://dx.doi.org/10.1016/S0006-2952(99)00206-3] [PMID:  10484074]

[57]
Hong, J.; Bose, M.; Ju, J.; Ryu, J-H.; Chen, X.; Sang, S.; Lee, M-J.; Yang, C.S. Modulation of arachidonic acid metabolism by curcumin and related  β-diketone derivatives: Effects on cytosolic phospholipase A(2), cyclooxygenases and 5-lipoxygenase. Carcinogenesis,  2004, 25(9), 1671-1679.
 [http://dx.doi.org/10.1093/carcin/bgh165] [PMID:  15073046]

[58]
Johnston, B.D.; DeMaster, E.G. Suppression of nitric oxide oxidation to nitrite by curcumin is due to the sequestration of the reaction intermediate nitrogen dioxide, not nitric oxide. Nitric Oxide,  2003, 8(4), 231-234.
 [http://dx.doi.org/10.1016/S1089-8603(03)00030-2] [PMID:  12895432]

[59]
Moon, D-O.; Kim, M-O.; Lee, H-J.; Choi, Y.H.; Park, Y-M.; Heo, M-S.; Kim, G-Y. Curcumin attenuates ovalbumin-induced airway inflammation by regulating nitric oxide. Biochem. Biophys. Res. Commun.,  2008, 375(2), 275-279.
 [http://dx.doi.org/10.1016/j.bbrc.2008.08.025] [PMID:  18706396]

[60]
Chainani-Wu, N. Safety and anti-inflammatory activity of curcumin: A component of tumeric (Curcuma longa). J. Altern. Complement. Med.,  2003, 9(1), 161-168.
 [http://dx.doi.org/10.1089/107555303321223035] [PMID:  12676044]

[61]
Ray, S.; Chattopadhyay, N.; Mitra, A.; Siddiqi, M.; Chatterjee, A. Curcumin exhibits antimetastatic properties by modulating integrin receptors, collagenase activity, and expression of Nm23 and E-cadherin. J. Environ. Pathol. Toxicol. Oncol.,  2003, 22(1), 49-58.
 [PMID:  12678405]

[62]
Kim, K.H.; Lee, E.N.; Park, J.K.; Lee, J.R.; Kim, J.H.; Choi, H.J.; Kim, B.S.; Lee, H.W.; Lee, K.S.; Yoon, S. Curcumin attenuates TNF-α-induced expression of intercellular adhesion molecule-1, vascular cell adhesion molecule-1 and proinflammatory cytokines in human endometriotic stromal cells. Phytother. Res.,  2012, 26(7), 1037-1047.
 [http://dx.doi.org/10.1002/ptr.3694] [PMID:  22183741]

[63]
Tu, C.T.; Yao, Q.Y.; Xu, B.L.; Zhang, S.C. Curcumin protects against concanavalin A-induced hepatitis in mice through inhibiting the cytoplasmic translocation and expression of high mobility group box 1. Inflammation,  2013, 36(1), 206-215.
 [http://dx.doi.org/10.1007/s10753-012-9536-4] [PMID:  22948514]

[64]
Ammon, H.P.; Anazodo, M.I.; Safayhi, H.; Dhawan, B.N.; Srimal, R.C. Curcumin: A potent inhibitor of leukotriene B4 formation in rat peritoneal polymorphonuclear neutrophils (PMNL). Planta Med.,  1992, 58(2), 226-226.
 [http://dx.doi.org/10.1055/s-2006-961438] [PMID:  1326775]

[65]
Jain, S.K.; Rains, J.; Croad, J.; Larson, B.; Jones, K. Curcumin supplementation lowers TNF-α IL-6, IL-8, and MCP-1 secretion in high glucose-treated cultured monocytes and blood levels of TNF-α IL-6, MCP-1, glucose, and glycosylated hemoglobin in diabetic rats. Antioxid. Redox Signal.,  2009, 11(2), 241-249.
 [http://dx.doi.org/10.1089/ars.2008.2140] [PMID:  18976114]

[66]
Kang, B.Y.; Chung, S.W.; Chung, W. Im, S.; Hwang, S.Y.; Kim, T.S. Inhibition of interleukin-12 production in lipopolysaccharide-activated macrophages by curcumin. Eur. J. Pharmacol.,  1999, 384(2-3), 191-195.
 [http://dx.doi.org/10.1016/S0014-2999(99)00690-1] [PMID:  10611441]

[67]
Marton, L.T.; Barbalho, S.M.; Sloan, K.P.; Sloan, L.A.; Goulart, R.A. Araújo, A.C.; Bechara, M.D. Curcumin, autoimmune and inflammatory diseases: Going beyond conventional therapy - a systematic review. Crit. Rev. Food Sci. Nutr.,  2022, 62(8), 2140-2157.
 [PMID:  33938775]

[68]
Kunnumakkara, A.B.; Bordoloi, D.; Padmavathi, G.; Monisha, J.; Roy, N.K.; Prasad, S.; Aggarwal, B.B. Curcumin, the golden nutraceutical: Multitargeting for multiple chronic diseases. Br. J. Pharmacol.,  2017, 174(11), 1325-1348.
 [http://dx.doi.org/10.1111/bph.13621] [PMID:  27638428]

[69]
Sharifi-Rad, J.; Rayess, Y.E.; Rizk, A.A.; Sadaka, C.; Zgheib, R.; Zam, W.; Sestito, S.; Rapposelli, S. Neffe-Skocińska, K.; Zielińska, D.; Salehi, B.; Setzer, W.N.; Dosoky, N.S.; Taheri, Y.; El Beyrouthy, M.; Martorell, M.; Ostrander, E.A.; Suleria, H.A.R.; Cho, W.C.; Maroyi, A.; Martins, N. Turmeric and its major compound curcumin on health: Bioactive effects and safety profiles for food, pharmaceutical, biotechnological and medicinal applications. Front. Pharmacol.,  2020, 11, 01021.
 [http://dx.doi.org/10.3389/fphar.2020.01021] [PMID:  33041781]

[70]
Haroyan, A.; Mukuchyan, V.; Mkrtchyan, N.; Minasyan, N.; Gasparyan, S.; Sargsyan, A.; Narimanyan, M.; Hovhannisyan, A. Efficacy and safety of curcumin and its combination with boswellic acid in osteoarthritis: A comparative, randomized, double-blind, placebo-controlled study. BMC Complement. Altern. Med.,  2018, 18(1), 7.
 [http://dx.doi.org/10.1186/s12906-017-2062-z] [PMID:  29316908]

[71]
Kotha, R.R.; Luthria, D.L. Curcumin: Biological, pharmaceutical, nutraceutical, and analytical aspects. Molecules,  2019, 24(16), E2930.
 [http://dx.doi.org/10.3390/molecules24162930] [PMID:  31412624]

[72]
Rahban, M.; Habibi-Rezaei, M.; Mazaheri, M.; Saso, L.; Moosavi-Movahedi, A.A. Anti-viral potential and modulation of nrf2 by curcumin: Pharmacological implications. Antioxidants,  2020, 9(12), 1228.
 [http://dx.doi.org/10.3390/antiox9121228] [PMID:  33291560]

[73]
Xu, G.; Gu, Y.; Yan, N.; Li, Y.; Sun, L.; Li, B. Curcumin functions as an anti-inflammatory and antioxidant agent on arsenic-induced hepatic and kidney injury by inhibiting MAPKs/NF-κB and activating Nrf2 pathways. Environ. Toxicol.,  2021, 36(11), 2161-2173.
 [http://dx.doi.org/10.1002/tox.23330] [PMID:  34272803]

[74]
Ghosh, S.S.; Gehr, T.W.B.; Ghosh, S. Curcumin and chronic kidney disease (CKD): Major mode of action through stimulating endogenous intestinal alkaline phosphatase. Molecules,  2014, 19(12), 20139-20156.
 [http://dx.doi.org/10.3390/molecules191220139] [PMID:  25474287]

[75]
White, C.M.; Pasupuleti, V.; Roman, Y.M.; Li, Y.; Hernandez, A.V. Oral turmeric/curcumin effects on inflammatory markers in chronic inflammatory diseases: A systematic review and meta-analysis of randomized controlled trials. Pharmacol. Res.,  2019, 146, 104280.
 [http://dx.doi.org/10.1016/j.phrs.2019.104280] [PMID:  31121255]

[76]
Jie, Z.; Chao, M.; Jun, A.; Wei, S. LiFeng, M Effect of curcumin on diabetic kidney disease: A systematic review and meta-analysis of randomized, double-blind, placebo-controlled clinical trials Evid. Based Complement. Altern. Med.,,  2021, 2021

[77]
Wang, Z-H.; Deng, L-H.; Chi, C-W.; Wang, H.; Huang, Y-Y.; Zheng, Q. A preclinical systematic review of curcumin for protecting the kidney with ischemia reperfusion injury. Oxid. Med. Cell. Longev.,  2020, 2020, 4546851-4546851.
 [http://dx.doi.org/10.1155/2020/4546851] [PMID:  33274000]

[78]
Gupta, S.C.; Patchva, S.; Aggarwal, B.B. Therapeutic roles of curcumin: Lessons learned from clinical trials. AAPS J.,  2013, 15(1), 195-218.
 [http://dx.doi.org/10.1208/s12248-012-9432-8] [PMID:  23143785]

[79]
Dei Cas, M.; Ghidoni, R. Dietary curcumin: Correlation between bioavailability and health potential. Nutrients,  2019, 11(9), 2147.
 [http://dx.doi.org/10.3390/nu11092147] [PMID:  31500361]

[80]
Chan, W.H.; Wu, H.Y.; Chang, W.H. Dosage effects of curcumin on cell death types in a human osteoblast cell line. Food Chem. Toxicol.,  2006, 44(8), 1362-1371.
 [http://dx.doi.org/10.1016/j.fct.2006.03.001] [PMID:  16624471]

[81]
Crewe, C.; An, Y.A.; Scherer, P.E. The ominous triad of adipose tissue dysfunction: Inflammation, fibrosis, and impaired angiogenesis. J. Clin. Invest.,  2017, 127(1), 74-82.
 [http://dx.doi.org/10.1172/JCI88883] [PMID:  28045400]

[82]
Mihai, S.; Codrici, E.; Popescu, I.D.; Enciu, A-M.; Albulescu, L.; Necula, L.G.; Mambet, C.; Anton, G.; Tanase, C. Inflammation-related mechanisms in chronic kidney disease prediction, progression, and outcome. J. Immunol. Res.,  2018, 2018, 2180373-2180373.
 [http://dx.doi.org/10.1155/2018/2180373] [PMID:  30271792]
Rights & Permissions Print Cite
Article Metrics
1
Journal Information
For Authors
For Editors
For Reviewers
Explore Articles
Open Access
Open Access Articles
For Visitors
DOI https://dx.doi.org/10.2174/2210315512666220617113802	Print ISSN 2210-3155
Publisher Name Bentham Science Publisher	Online ISSN 2210-3163
The Natural Products Journal

Effect of Curcumin on Oxidative Stress, Inflammatory Response and Kidney Biochemical Parameters Among Kidney Disease Patients: A Systematic Review

Abstract Play Pause

Related Journals

Related Books

Abstract
